Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CP 154526

Known as: CP 154,526, CP-154,526, CP-154526 
 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

PyrimidinesPyrroles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
α2 Adrenergic and Imidazoline Receptor Agonists Prevent Cue-Induced Cocaine Seeking
BACKGROUND Drug-associated cues can elicit stress-like responses in addicted individuals, indicating that cue- and stress-induced… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2008
2008
The CRF-1 receptor antagonist, CP-154,526, attenuates stress-induced increases in ethanol consumption by BALB/cJ mice.
BACKGROUND Corticotropin-releasing factor (CRF) signaling modulates neurobiological responses to stress and ethanol, and may… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Blockade of the corticotropin releasing factor type 1 receptor attenuates elevated ethanol drinking associated with drinking in the dark procedures.
BACKGROUND Drinking in the dark (DID) procedures have recently been developed to induce high levels of ethanol drinking in C57BL… Expand
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Region-specific effects of brain corticotropin-releasing factor receptor type 1 blockade on footshock-stress- or drug-priming-induced reinstatement of morphine conditioned place preference in rats
RationaleSystemic injections of the selective corticotropin-releasing factor 1 (CRF1) receptor antagonist CP-154,526 attenuate… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Modulation of multiple ethanol withdrawal-induced anxiety-like behavior by CRF and CRF1 receptors
Previous work demonstrated that rats subjected to multiple withdrawals from chronic ethanol exhibit a sensitization of anxiety… Expand
Is this relevant?
2003
2003
Involvement of corticotropin-releasing hormone receptor subtypes 1 and 2 in peripheral opioid-mediated inhibition of inflammatory pain
In painful inflammation, exogenous as well as endogenous corticotropin-releasing hormone (CRH) can release opioid peptides… Expand
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Differential actions of peripheral corticotropin-releasing factor (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice: role of CRF receptor subtypes 1 and 2.
Peripheral CRF inhibits gastric emptying and stimulates colonic motor function in rats. We investigated the role of CRF(1) and… Expand
  • table 1
  • figure 2
  • figure 1
  • figure 3
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents Comparison with diazepam and buspirone
Abstract The present series of experiments compared the behavioral effects of the novel non-peptide CRF antagonist CP-154,526… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
1996
Highly Cited
1996
A non peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activity.
The multiple actions of corticotropin-releasing factor (CRF) on neuroendocrine and behavioural functions can now be examined… Expand
Is this relevant?
Highly Cited
1996
Highly Cited
1996
CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.
Here we describe the properties of CP-154,526, a potent and selective nonpeptide antagonist of corticotropin (ACTH) releasing… Expand
  • figure 1
  • table 1
  • figure 3
  • figure 2
  • figure 4
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE